Ciprofloxacin and Gemzar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ciprofloxacin (ciprofloxacin) and Gemzar (gemcitabine hydrochloride). Common drug interactions include pain among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Ciprofloxacin and Gemzar. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Ciprofloxacin?

Ciprofloxacin has active ingredients of ciprofloxacin. It is often used in urinary tract infection. eHealthMe is studying from 22,256 Ciprofloxacin users. Check the latest studies of Ciprofloxacin.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

15 people who take Ciprofloxacin and Gemzar together, and have interactions are studied.

Ciprofloxacin and Gemzar drug interactions.

What are the common drug interactions of Ciprofloxacin and Gemzar, by gender? *:

female:

  1. Pain
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Alanine aminotransferase increased
  4. Anaemia (lack of blood)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Atelectasis (partial or complete collapse of the lung)
  8. Bone fragmentation
  9. Breath odour
  10. Cachexia (loss of weight)

male:

  1. Anxiety
  2. Bone disorder
  3. Fall
  4. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  5. Intervertebral disc protrusion (spinal disc protrusion)
  6. Mastication disorder (disease of chewing food)
  7. Pleural effusion (water on the lungs)
  8. Anaemia (lack of blood)
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Atelectasis (partial or complete collapse of the lung)

What are the common drug interactions of Ciprofloxacin and Gemzar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Amphetamines positive
  2. Anxiety
  3. Bone disorder
  4. Bone erosion
  5. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  6. Cataract (clouding of the lens inside the eye)
  7. Cellulitis (infection under the skin)
  8. Chest wall mass
  9. Constipation
  10. Decreased interest

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Hepatocellular injury (liver injury)

40-49:

  1. Pain
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Anaemia (lack of blood)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Atelectasis (partial or complete collapse of the lung)
  7. Bone fragmentation
  8. Breath odour
  9. Cachexia (loss of weight)
  10. Conjunctival haemorrhage (bleeding underneath the conjunctiva)

50-59:

  1. Impaired healing
  2. Injury
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Mastication disorder (disease of chewing food)
  5. Metastases to bone (cancer spreads to bone)
  6. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Pain
  9. Abdominal pain lower
  10. Abdominal pain upper

60+:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  3. Pulmonary alveolar haemorrhage (acute bleeding)

What are the existing conditions these people have? *

  1. Ovarian Cancer Metastatic (cancer of ovary spreads to other organ or parts): 6 people, 40.00%
  2. Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 6 people, 40.00%
  3. Breast Cancer: 3 people, 20.00%
  4. Insomnia (sleeplessness): 2 people, 13.33%
  5. Nausea And Vomiting: 2 people, 13.33%
  6. Nausea (feeling of having an urge to vomit): 2 people, 13.33%
  7. High Blood Pressure: 1 person, 6.67%
  8. Breast Cancer Metastatic: 1 person, 6.67%
  9. Constipation: 1 person, 6.67%
  10. Depression: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ciprofloxacin and Gemzar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ciprofloxacin and Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ciprofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ciprofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gemzar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin and gemcitabine hydrochloride (the active ingredients of Ciprofloxacin and Gemzar, respectively), and Ciprofloxacin and Gemzar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: